주식회사 서해홀딩스

01 Understanding Global Demand

To drive Global Licensing, it is essential to have a deep understanding of the global bio/new drug market and to be well-informed about development directions. Additionally, it is crucial to grasp the evolving demands of global pharmaceutical companies regarding the technologies they are seeking.

02 Developing Prospective Technologies for Global Licensing

Based on this understanding, we aim to identify technologies that align with global demand by conducting invention interviews, lab tour, consulting of inventors, securing intellectual property (IP), and establishing an IP portfolio through IP R&D with Universities, government-funded Research Institutes, and Biotech Venture companies. After confirming the research and development commitment of inventors, we review those technologies with high potential for Global Licensing, prioritize these technologies, and develop a technology marketing strategy. If there are shortcomings in the Global Licensing process, we provide consulting to adjust and enhance the technology development direction.

03 Procedure for Global Licensing

To prepare for Global Licensing, we analyze the global markets corresponding to each technology area and thoroughly review the regulatory requirements to meet with the U.S. FDA, European EMA, and the domestic Ministry of Food and Drug Safety. This allows us to establish strategies that can leverage these regulations. We conduct demand analysis, competitor analysis, SWOT analysis, and business model development, establishing a clear concept for the target technology while preparing analytical materials, pitch books, and technology introduction documents that effectively showcase the strengths of the technology. Accordingly, we develop a Global Licensing strategy.

04 Attending Conferences and Partnering with Demand Companies

Once prepared for Global Licensing strategy, we reach out to demand companies through our established global network and participate in conferences both domestically and internationally to perform technology marketing. We introduce the target technology and identify genuine demand companies.

05 Conducting the Global Licensing Process

After contacting suitable demand companies, we proceed through the stages of introducing the technology, arranging meetings, conducting Zoom meetings, signing confidentiality agreements (CDA), performing due diligence, signing letters of intent (LOI), executing material transfer agreements (MTA), receiving term sheets, and ultimately finalizing contracts and receiving upfront payments .

06 Final Goal

Our ultimate goal is to assist Universities, government-funded Research Institutes, and early-stage Biotech Ventures in Global Licensing, thereby promoting bio/new drug technology development. We aim to ensure that outstanding technologies are successfully developed in the global market .